BofA upgraded Albemarle to Neutral from Underperform with a price target of $149, down from $154. While trimming the firm’s 2024 EBITDA estimate, the firm sees modest downside risk as it notes that Albemarle shares have fallen by more than half year-to-date.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ALB: